Absence of fetal cells in maternal circulation at a level of 1 in 25,000
โ Scribed by Nakagome, Yasuo ;Seki, Satoko ;Nagafuchi, Shigeo ;Nakahori, Yutaka ;Sato, Kodo
- Publisher
- John Wiley and Sons
- Year
- 1991
- Tongue
- English
- Weight
- 355 KB
- Volume
- 40
- Category
- Article
- ISSN
- 0148-7299
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
The development of a non-invasive prenatal diagnostic test using fetal nucleated red blood cells (NRBCs) isolated from the maternal circulation is hampered by the low frequency of these cells in maternal blood, requiring extensive enrichment procedures before any analytical procedure can be performe
Prenatal diagnosis of fetal chromosomal abnormalities using interphase fetal nucleated erythrocytes (FNRBCs) separated from maternal peripheral blood can be technically challenging due to the limited number of FNRBCs available for analysis, the limited number of probes that can be used simultaneousl
## To the Editor: Fetal nucleated erythrocytes circulating in maternal blood are a potential source of fetal DNA for noninvasive prenatal genetic diagnoses. Nucleated red blood cells (NRBCs) have several advantages over fetal lymphocytes, granulocytes, or trophoblasts. They are nucleated, and thus
Fetal cells are present in the circulation of pregnant women and can be isolated using density gradient centrifugation and magnetic cell sorting. In the present study, maternal cell preparations were depleted for CD45and CD14-positive cells and enriched for CD71-positive cells. The number of fetal n
In a study of 2923 normal pregnancies and 203 pregnancies affected by trisomy 21 we have shown a signiยฎcant difference in the median MoM of the markers: fetal nuchal translucency, maternal serum free b-hCG and PAPP-A in the presence of a female fetus compared with a male fetus. For maternal serum fr